Page 3 - Teligent Inc News Today

Two pharmaceutical companies have issued recalls in December due to manufacturing issues that may impact the safety and quality of their drug products.

An unexpected lawsuit that emerged earlier this year from Insys Therapeutics Inc.'s bankruptcy case in Delaware raised concerns on Friday among Teligent Inc.'s largest pharmaceutical distributors that the bankrupt generic-drug manufacturer could put their customer programs at risk.

/PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company ("Teligent" or the "Company"), today announced that...

Generic pharmaceutical company Teligent Inc. sought Chapter 11 protection in Delaware on Thursday with nearly $130 million in debt and plans for a sale, saying it has been dealing with "regulatory headwinds" and the impact of the COVID-19 pandemic.

Generic pharmaceutical company Teligent Inc. sought Chapter 11 protection in Delaware on Thursday with nearly $130 million in debt and plans for a sale, saying it has been dealing with "regulatory headwinds" and the impact of the COVID-19 pandemic.

(Bloomberg) -- Teligent Inc., a beleaguered generic drug maker, filed for court protection from creditors on Thursday with plans to sell itself. The publicly traded company listed assets of as much as $100 million and liabilities of as much as $500 million in its bankruptcy petition.

BUENA, N.J. (AP) _ Teligent Inc. (TLGT) on Monday reported a loss of $12.9 million in its...

Lignocaine Market to Witness Revolutionary Growth by 2026 | AstraZeneca, Pfizer, Glenmark Pharma, Centura, Teligent

A The latest price target for Teligent (NASDAQ: TLGT) was reported byCraig-Hallum on 2020-08-20. The analyst firm set a price target for2.00 expecting TLGT to rise to within 12 months (a possible 272.37% upside). 1 analyst firms have reported ratings in the last year. Q A The stock price for Teligent (NASDAQ: TLGT) is $0.5371 last updatedFri May 28 2021 20:00:02 GMT+0000 (Coordinated Universal Time). Q A Q A Q A Popular Channels

Teligent: Q1 Earnings Snapshot FacebookTwitterEmail BUENA, N.J. (AP) _ Teligent Inc. (TLGT) on Tuesday reported first-quarter net income of $2.2 million, after reporting a loss in the same period a year earlier. On a per-share basis, the Buena, New Jersey-based company said it had profit of 3 cents. Losses, adjusted for restructuring gains, came to 20 cents per share. The specialty generic pharmaceutical company posted revenue of $11.6 million in the period. The companys shares closed at 52 cen...